ACTRN12615000376549终止不适用
Effect of low dose Atomoxetine on stress/anxiety levels and cardiovascular risk in patients with hypertension, hypercholesterolemia, diabetes or other cardiovascular disease.
Professor Simon Dimmitt0 个研究点目标入组 20 人开始时间: 2015年4月23日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •currently prescribed medication to treat hypertension, hypercholesterolaemia or diabetes; or have previously suffered an arterial clinical event such as angina, acute myocardial infarction, transient ischemic event, stroke or retinal infarct/haemorrhage; and have a body mass index of greater than 25; and elevated DASS sub scale score (stress > 4, anxiety > 4 or depression > 4)
排除标准
- •unstable physical illness, clinical and/or questionnaire evidence of major psychiatric disorder and/or patients currently on psychotropic medication, a DASS score > 21, patients with atrial fibrillation or blood pressure > 170/110
研究者
相似试验
招募中
2 期
Study of the effect of Atomoxetine on cognitive symptoms in patients with schizophreniaIRCT20101130005280N31Mashhad University of Medical Sciences42
尚未招募
3 期
Atomoxetine for cognitive impairment in Behcet's diseaseBehcet's diseaseIRCT20211206053288N1Tehran University of Medical Sciences40
招募中
3 期
The Effect of Atomoxetine on Cognitive Symptoms in Schizophrenia PatientsSchizophreniaIRCT20211219053452N1Arak University of Medical Sciences40
进行中（未招募）
不适用
Effect of Atomoxetine and a standardized behavior therapy on attention deficits in adult ADHD - Atomoxetine and adult ADHDAdult Attention Deficit Hyperactivity DisorderMedDRA version: 8.1Level: LLTClassification code 10003735Term: Attention deficit-hyperactivity disorderEUCTR2006-004073-10-DEniversity of Giessen
进行中（未招募）
1 期
Evaluation of the effect of Atomoxetine on impulsive state of High impulsive Tourette’s patients.EUCTR2019-004455-36-FRCHU DE POITIERS45